Simplex Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.1M | Sell |
2,248,600
-1,668,200
| -43% | -$44.4M | 0.04% | 184 |
|
|
2025
Q4 | $97.5M | Sell |
3,916,800
-843,800
| -18% | -$21.3M | 0.06% | 159 |
|
|
2025
Q3 | $121M | Sell |
4,760,600
-458,400
| -9% | -$11.3M | 0.06% | 156 |
|
|
2025
Q2 | $95.8M | Buy |
5,219,000
+747,300
| +17% | +$17.4M | 0.05% | 166 |
|
|
2025
Q1 | $113M | Sell |
4,471,700
-1,969,000
| -31% | -$51.5M | 0.07% | 129 |
|
|
2024
Q4 | $171M | Buy |
6,440,700
+1,349,800
| +27% | +$36.6M | 0.1% | 105 |
|
|
2024
Q3 | $97.5M | Buy |
5,090,900
+388,400
| +8% | +$11.3M | 0.06% | 165 |
|
|
2024
Q2 | $104M | Buy |
4,702,500
+1,022,400
| +28% | +$28.1M | 0.06% | 151 |
|
|
2024
Q1 | $102M | Sell |
3,680,100
-753,800
| -17% | -$20.9M | 0.06% | 171 |
|
|
2023
Q4 | $100M | Buy |
4,433,900
+1,531,200
| +53% | +$46.3M | 0.06% | 183 |
|
|
2023
Q3 | $96.3M | Buy |
2,902,700
+599,100
| +26% | +$21.2M | 0.08% | 141 |
|
|
2023
Q2 | $84.5M | Buy |
2,303,600
+684,400
| +42% | +$26.6M | 0.07% | 175 |
|
|
2023
Q1 | $66.1M | Sell |
1,619,200
-1,504,500
| -48% | -$65M | 0.06% | 231 |
|
|
2022
Q4 | $160M | Buy |
3,123,700
+1,141,000
| +58% | +$54.7M | 0.17% | 73 |
|
|
2022
Q3 | $86.7M | Sell |
1,982,700
-295,400
| -13% | -$14.4M | 0.1% | 138 |
|
|
2022
Q2 | $119M | Sell |
2,278,100
-783,200
| -26% | -$39.9M | 0.13% | 88 |
|
|
2022
Q1 | $158M | Sell |
3,061,300
-1,630,600
| -35% | -$84.6M | 0.14% | 91 |
|
|
2021
Q4 | $275M | Buy |
4,691,900
+1,467,800
| +46% | +$72.7M | 0.28% | 47 |
|
|
2021
Q3 | $123M | Sell |
3,224,100
-14,100
| -0.4% | -$625K | 0.12% | 110 |
|
|
2021
Q2 | $123M | Buy |
3,238,200
+3,216,660
| +14,933% | +$125M | 0.12% | 107 |
|
|
2021
Q1 | $71M | Sell |
21,540
-18,707
| -46% | -$664K | 0.13% | 101 |
|
|
2020
Q4 | $78.9M | Buy |
40,247
+6,928
| +21% | +$254K | 0.1% | 117 |
|
|
2020
Q3 | $116M | Buy |
33,319
+25,342
| +318% | +$888K | 0.16% | 71 |
|
|
2020
Q2 | $24.7M | Sell |
7,977
-5,828
| -42% | -$198K | 0.04% | 252 |
|
|
2020
Q1 | $42.8M | Buy |
13,805
+8,925
| +183% | +$304K | 0.08% | 133 |
|
|
2019
Q4 | $18.1M | Sell |
4,880
-2,343
| -32% | -$83.5K | 0.04% | 305 |
|
|
2019
Q3 | $24.6M | Buy |
7,223
+3,797
| +111% | +$138K | 0.07% | 206 |
|
|
2019
Q2 | $14.1M | Sell |
3,426
-2,566
| -43% | -$102K | 0.04% | 308 |
|
|
2019
Q1 | $24.1M | Sell |
5,992
-1,666
| -22% | -$66.7K | 0.07% | 180 |
|
|
2018
Q4 | $31.7M | Buy |
7,658
+3,924
| +105% | +$163K | 0.09% | 132 |
|
|
2018
Q3 | $15.6M | Sell |
3,734
-99
| -3% | -$3.81K | 0.05% | 246 |
|
|
2018
Q2 | $13.2M | Buy |
3,833
+889
| +30% | +$30.4K | 0.05% | 273 |
|
|
2018
Q1 | $272K | Buy |
2,944
+1,507
| +105% | +$51.8K | 0.01% | 1041 |
|
|
2017
Q4 | $186K | Sell |
1,437
-2,341
| -62% | -$79.8K | 0.01% | 1324 |
|
|
2017
Q3 | $796K | Buy |
3,778
+2,080
| +122% | +$66.9K | 0.03% | 455 |
|
|
2017
Q2 | $104K | Sell |
1,698
-1,350
| -44% | -$42.6K | ﹤0.01% | 1727 |
|
|
2017
Q1 | $254K | Buy |
3,048
+89
| +3% | +$2.81K | 0.01% | 1068 |
|
|
2016
Q4 | $409K | Buy |
2,959
+847
| +40% | +$25.9K | 0.02% | 641 |
|
|
2016
Q3 | $396K | Sell |
2,112
-1,092
| -34% | -$36.5K | 0.03% | 622 |
|
|
2016
Q2 | $1.02M | Buy |
3,204
+1,219
| +61% | +$38.9K | 0.07% | 270 |
|
|
2016
Q1 | $89K | Buy |
1,985
+559
| +39% | +$16K | 0.01% | 1454 |
|
|
2015
Q4 | $156K | Sell |
1,426
-2,291
| -62% | -$72.1K | 0.01% | 1047 |
|
|
2015
Q3 | $564K | Buy |
3,717
+3,254
| +703% | +$104K | 0.04% | 403 |
|
|
2015
Q2 | $12K | Sell |
463
-488
| -51% | -$15.9K | ﹤0.01% | 2923 |
|
|
2015
Q1 | $394K | Buy |
951
+527
| +124% | +$16.8K | 0.05% | 401 |
|
|
2014
Q4 | $82K | Buy |
+424
| New | +$12.2K | 0.01% | 1048 |
|
Other funds holding PFE
VCM
VPM
Simplex Trading's PFE Position: Q1 2026 in Review
Simplex Trading reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $5.97M and leaving 1,266,685 shares worth $35.6M. The position accounts for 0.02% of the portfolio, ranked #292.
Simplex Trading first reported a position in PFE in Q2 2015 and has held it in 34 quarters since. The position peaked at $128M in Q1 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Simplex Trading held 1,266,685 shares of Pfizer worth $35.6M as of Q1 2026.
- Simplex Trading sold 224,352 Pfizer shares in Q1 2026, an estimated $5.97M.
- Pfizer made up 0.02% of Simplex Trading's portfolio in Q1 2026, its #292 holding.
- Simplex Trading first reported a position in Pfizer in Q2 2015 and has held it in 34 quarters since.
- Simplex Trading's Pfizer position peaked at $128M in Q1 2024.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.